Oncology

Screening, Surveillance, and Life After Treatment

At a Glance

After lung cancer treatment, follow-up scans depend on the cancer type and treatment history: non-small cell cancer often uses CT every six months for two years, then yearly; small cell cancer may need more frequent CT and brain MRI. Care also addresses lasting symptoms and anxiety.

Completing treatment for lung cancer is a major milestone, but it also marks the beginning of a new phase: survivorship. This journey involves proactive monitoring to catch any changes early and addressing the long-term physical and emotional effects of the disease and its treatment, whether you have finished all active therapy or remain on ongoing maintenance treatment ^[1]^[2].

Lung Cancer Screening: Who Needs It?

Screening is for people who do not have symptoms but are at higher risk for developing lung cancer. The goal is to find cancer at its earliest, most treatable stage ^[3].

Standard Eligibility (USPSTF): Annual Low-Dose CT (LDCT) is recommended for adults aged 50 to 80 who have a 20 “pack-year” smoking history (the equivalent of one pack a day for 20 years) and who currently smoke or have quit within the past 15 years ^[3]^[4].
When to Stop: Screening typically stops once you reach age 80, have been smoke-free for 15 years, or develop a health condition that would make curative surgery or treatment impossible ^[3]^[5].
A Note on Quitting: If you currently smoke, quitting is the single most effective way to lower your risk of a new lung cancer or complications ^[6]. Your screening visits are a judgment-free opportunity to access proven counseling and medications to help you stop ^[6]^[7].

Surveillance: Monitoring After Treatment

Once you have finished curative-intent treatment (like surgery or radiation), your doctors will move you to a surveillance schedule. This is different from screening; these scans are designed to monitor your recovery and check for any signs of the original cancer returning (recurrence) ^[8]^[9]. It is important to note that surveillance CT scans satisfy the imaging plan that would otherwise be called annual LDCT, and duplicate scans should not be scheduled automatically, although survivors remain at risk for a second primary lung cancer.

For Non-Small Cell Lung Cancer (NSCLC)

Years 1 and 2: Most guidelines (such as ASCO) recommend a chest CT scan every 6 months ^[8].
Year 3 and Beyond: If your scans remain clear, you will typically move to an annual (once a year) CT scan ^[8].
Important Note: Routine PET/CT scans and brain MRIs are generally not recommended for routine monitoring in NSCLC unless you develop new symptoms or a CT scan shows something suspicious ^[8]^[9].

For Small Cell Lung Cancer (SCLC)

Because SCLC can be more aggressive, monitoring is often more frequent.

Chest Monitoring: You will have regular CT scans, often every 3 to 6 months for the first few years ^[10].
Brain Monitoring: Because PCI reduces but does not completely eliminate the risk of brain metastases, many protocols use scheduled brain MRIs even after you receive Prophylactic Cranial Irradiation (PCI), as well as when PCI is not given. Your team will likely schedule brain MRIs every 3 months for the first two years to catch any spread early ^[11]^[12].

Never wait for a scheduled scan if you develop new or worsening symptoms between visits. Contact your care team promptly.

Navigating ‘Scanxiety’ and Emotional Health

It is completely normal to feel a surge of fear or distress in the days or weeks leading up to a follow-up scan—a phenomenon often called scanxiety ^[13]^[14].

Validate Your Feelings: Fear of recurrence is common among survivors ^[13]. This isn’t a sign of weakness; it is a natural response to a traumatic experience ^[15].
Coping Strategies: Many survivors find relief through Mindfulness-Based Stress Reduction (MBSR), support groups, or “behavioral activation” (staying active and engaged in meaningful tasks) ^[16]^[17]. If your anxiety feels overwhelming, ask your team for a referral to an oncology social worker or psychologist ^[18].

Long-Term Survivorship and Quality of Life

Survival is about more than just the absence of cancer; it is about living well. Many survivors deal with lingering side effects, such as fatigue (profound tiredness), dyspnea (shortness of breath), or “chemo brain” (mild cognitive changes) ^[19]^[20].

Pulmonary Rehabilitation: This is a structured program of exercise and education that can significantly improve your breathing and energy levels after lung surgery or radiation ^[2]^[21].
Symptom Management: Don’t assume that pain or breathlessness is just “the way things are now.” There are many supportive care options to help you regain your strength and independence ^[2]^[18].

Common questions in this guide

Who should have low-dose CT screening for lung cancer?

For people without symptoms, annual low-dose CT is generally recommended for adults ages 50 to 80 who have a 20 pack-year smoking history and currently smoke or quit within the past 15 years. Screening usually ends at age 80, after 15 smoke-free years, or if a serious health condition would prevent curative treatment.

How often should I have CT scans after treatment for non-small cell lung cancer?

After curative-intent treatment for non-small cell lung cancer, chest CT is commonly performed every six months during the first two years. If scans remain clear, follow-up usually changes to once a year from year three onward.

What scans are used to monitor small cell lung cancer after treatment?

Small cell lung cancer often requires chest CT every three to six months during the first few years. Many follow-up plans also use brain MRI about every three months for the first two years, whether or not preventive brain radiation was given; your team will individualize the schedule.

Do I need routine PET scans or brain MRIs after non-small cell lung cancer treatment?

Routine PET/CT scans and brain MRI are generally not recommended for monitoring non-small cell lung cancer when you have no new symptoms and CT findings are not concerning. Your team may order them if symptoms develop or a CT scan shows something suspicious.

Does follow-up surveillance replace annual lung cancer screening?

After lung cancer treatment, surveillance CT scans are designed to check for recurrence and generally cover the imaging that an annual low-dose CT screening visit would otherwise provide. Do not schedule duplicate scans automatically, but continue discussing the risk of a second primary lung cancer with your care team.

What can I do about anxiety before lung cancer scans?

Fear before follow-up scans, sometimes called scanxiety, is common after lung cancer treatment. Mindfulness practice, support groups, and staying active with meaningful tasks may help; ask for an oncology social worker or psychologist if anxiety is overwhelming.

Can pulmonary rehabilitation help me recover after lung cancer treatment?

Pulmonary rehabilitation combines structured exercise and education and may improve breathing and energy after lung surgery or radiation. Ask your care team whether a referral is appropriate, and report ongoing pain or shortness of breath rather than assuming it must continue.

Curated prompts to bring to your next appointment.

1.Based on my treatment, what is my individualized schedule for follow-up CT scans?
2.How does my surveillance scan schedule overlap with or replace annual LDCT screening?
3.What specific long-term side effects—like lung scarring, neuropathy, or fatigue—should I be watching for and reporting?
4.What is the plan for monitoring my brain with MRI scans going forward?
5.Can you refer me to a pulmonary rehabilitation program or a survivorship clinic?

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

Key takeaways

Annual low-dose CT screening is recommended for adults ages 50 to 80 with a 20 pack-year smoking history who currently smoke or quit within 15 years, if they could undergo curative treatment.
After non-small cell lung cancer treatment, surveillance commonly uses chest CT every six months for two years, then annually if scans remain clear.
After small cell lung cancer treatment, chest CT is often performed every three to six months initially, and brain MRI may be scheduled every three months for the first two years.
Surveillance CT may replace overlapping annual low-dose CT screening, while routine PET/CT and brain MRI are generally not used for non-small cell lung cancer unless symptoms or suspicious CT findings arise.
Survivorship care can address scanxiety, fatigue, breathlessness, cognitive changes, smoking cessation, and physical recovery through support and pulmonary rehabilitation.

References (21)

1
Lung Cancer Survivorship: Challenges and Care Needs.
Cani M, Cotogni P, Greco A, et al.
Cancers 2026; (18(17)) doi:10.3390/cancers18172856.
PMID: 42738376
2
Implementation and Effectiveness of a Veterans Affairs-Based Comprehensive Lung Cancer Survivorship Program.
Rabe BJ, Stafford JW, Hassinger AD, et al.
Journal of cardiopulmonary rehabilitation and prevention 2022; (42(3)):196-201 doi:10.1097/HCR.0000000000000658.
PMID: 34840244
3
Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement.
, Krist AH, Davidson KW, et al.
JAMA 2021; (325(10)):962-970 doi:10.1001/jama.2021.1117.
PMID: 33687470
4
Lung Cancer Screening.
Choi HK, Mazzone PJ
The Medical clinics of North America 2022; (106(6)):1041-1053 doi:10.1016/j.mcna.2022.07.007.
PMID: 36280331
5
Shared decision-making conversations and smoking cessation interventions: critical components of low-dose CT lung cancer screening programs.
Lowenstein LM, Deyter GMR, Nishi S, et al.
Translational lung cancer research 2018; (7(3)):254-271 doi:10.21037/tlcr.2018.05.10.
PMID: 30050764
6
Pairing smoking-cessation services with lung cancer screening: A clinical guideline from the Association for the Treatment of Tobacco Use and Dependence and the Society for Research on Nicotine and Tobacco.
Fucito LM, Czabafy S, Hendricks PS, et al.
Cancer 2016; (122(8)):1150-9 doi:10.1002/cncr.29926.
PMID: 26916412
7
The American Cancer Society National Lung Cancer Roundtable strategic plan: Tobacco treatment in the context of lung cancer screening.
Fathi JT, Cinciripini PM, DePrimo MJ, et al.
Cancer 2025; (131(18)):e35972 doi:10.1002/cncr.35972.
PMID: 40928189
8
Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline.
Schneider BJ, Ismaila N, Aerts J, et al.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(7)):753-766 doi:10.1200/JCO.19.02748.
PMID: 31829901
9
Surveillance With Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography of Patients With Stage I-to-III Lung Cancer After Completion of Curative treatment (SUPE_R): A Randomized Controlled Trial.
Guldbrandsen KF, Bloch M, Skougaard K, et al.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2025; (20(8)):1086-1097 doi:10.1016/j.jtho.2025.04.003.
PMID: 40258572
10
Small Cell Lung Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
Ganti AKP, Loo BW, Bassetti M, et al.
Journal of the National Comprehensive Cancer Network : JNCCN 2021; (19(12)):1441-1464.
PMID: 34902832
11
Rational and design of prophylactic cranial irradiation (PCI) and brain MRI surveillance versus brain MRI surveillance alone in patients with limited-stage small cell lung cancer achieving complete remission (CR) of tumor after chemoradiotherapy: a multicenter prospective randomized study.
Chen M, Li R, Kong Y, et al.
BMC cancer 2024; (24(1)):429 doi:10.1186/s12885-024-12123-x.
PMID: 38589800
12
Radiation Therapy for Small Cell Lung Cancer: An ASTRO Clinical Practice Guideline.
Simone CB, Bogart JA, Cabrera AR, et al.
Practical radiation oncology 2020; (10(3)):158-173 doi:10.1016/j.prro.2020.02.009.
PMID: 32222430
13
Screening for fear of cancer recurrence: Instrument validation and current status in early stage lung cancer patients.
Lee YH, Hu CC, Humphris G, et al.
Journal of the Formosan Medical Association = Taiwan yi zhi 2020; (119(6)):1101-1108 doi:10.1016/j.jfma.2019.10.007.
PMID: 31677865
14
Fear of cancer recurrence across the survivorship trajectory: Results from a survey of adult long-term cancer survivors.
Götze H, Taubenheim S, Dietz A, et al.
Psycho-oncology 2019; (28(10)):2033-2041 doi:10.1002/pon.5188.
PMID: 31364222
15
Post-traumatic stress symptoms in long-term disease-free cancer survivors and their family caregivers.
De Padova S, Grassi L, Vagheggini A, et al.
Cancer medicine 2021; (10(12)):3974-3985 doi:10.1002/cam4.3961.
PMID: 34061453
16
Efficacy of behavioral activation in reducing fear of cancer recurrence in non-small cell lung cancer patients: a randomized controlled trial.
Ge H, Li A, Huang R, et al.
American journal of cancer research 2025; (15(4)):1806-1819 doi:10.62347/ZSKM4538.
PMID: 40371137
17
The effect of psychological interventions on fear of cancer recurrence in breast cancer survivors: A systematic review and meta-analysis.
Lyu MM, Siah RC, Lam ASL, Cheng KKF
Journal of advanced nursing 2022; (78(10)):3069-3082 doi:10.1111/jan.15321.
PMID: 35696315
18
Survivorship in Advanced Lung Cancer: Understanding a New Landscape and Opportunities.
Presley CJ, Dalal N, Davenport AP, et al.
American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2024; (44(3)):e433298 doi:10.1200/EDBK_433298.
PMID: 38768420
19
A Systematic Review and Narrative Synthesis to Explore the Effectiveness of Exercise-Based Interventions in Improving Fatigue, Dyspnea, and Depression in Lung Cancer Survivors.
Henshall CL, Allin L, Aveyard H
Cancer nursing 2019; (42(4)):295-306 doi:10.1097/NCC.0000000000000605.
PMID: 29787385
20
Cognitive functioning in long-term cancer survivorship: A survey utilizing both standardized neuropsychological and self-report measures.
Muzzatti B, Giovannini L, Flaiban C, et al.
Applied neuropsychology. Adult 2019; (26(2)):173-180 doi:10.1080/23279095.2017.1387551.
PMID: 29099636
21
Effects of a rehabilitation program based on home intelligent management platform guided among patient after lung cancer surgery: a randomized controlled trail.
Wang L, Liu C, Li H, et al.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2026; (34(4)).
PMID: 41896472

This page is for informational purposes only and does not constitute medical advice. Your oncology team should tailor screening, follow-up scans, symptom evaluation, and survivorship care to your history.

Get notified when new evidence is published on lung cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Guide Contents